Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|13|7|997-1004

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.13, Iss.7, 2013-01, pp. : 997-1004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Uniqueness of the Trypanosoma cruzi Mitochondrion: Opportunities to Target New Drugs Against Chagas' Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 20, 2011-07 ,pp. : 2074-2099

Bentham Science Publishers

Access to resources Recommend Favorite

Natural and Synthetic Naphthoquinones Active Against Trypanosoma Cruzi: An Initial Step Towards New Drugs for Chagas Disease

By  

Current Medicinal Chemistry, Vol. 18, Iss. 1, 2011-01 ,pp. : 144-161

Bentham Science Publishers

Access to resources Recommend Favorite

Proteinases of Trypanosoma cruzi: Potential Targets for the Chemotherapy of Chagas Disease

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 6, 2005-01 ,pp. : 495-504

Bentham Science Publishers

Access to resources Recommend Favorite

Proteinases of Trypanosoma Cruzi: Potential Targets for the Chemotherapy of Chagas Disease

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 11, 2002-11 ,pp. : 1261-1271

Bentham Science Publishers

Access to resources Recommend Favorite

The Major Cysteine Proteinase of Trypanosoma cruzi: A Valid Target for Chemotherapy of Chagas Disease

By  

Current Pharmaceutical Design, Vol. 7, Iss. 12, 2001-08 ,pp. : 1143-1156

Bentham Science Publishers

Access to resources Recommend Favorite